Productivity and Innovation

Yasuyuki Todo, Petr Matous, 26 June 2015

Firm networks affect innovation and growth through diffusion of knowledge and information. This column argues that promoting ties with firms outside of the region should be an important part of cluster policies. Such ties can bring new information to the region and can enhance innovation. Distant firm partners can also help in the short-run recovery after a disaster, as was the case following the 2011 earthquake in Japan.

Rune Dahl Fitjar, Andrés Rodríguez-Pose, 24 June 2015

Policymakers have used a variety of measures to promote firm innovation but their exact impact remains unclear. This column argues that regional context, proxied by investment in R&D and education levels, is fundamental in shaping the innovative performance of firms. The local socioeconomic environment either favours or limits the innovative capacity of firms, depending on their level of interaction both with neighbouring and distant economic actors.

Virginia Di Nino, 08 June 2015

The high-flying productivity of exporting firms is one of the reasons governments promote exporting. This column presents new evidence on ‘carry along trade’, i.e. exports by firms who did not produce the final good. In Italy, about a quarter of manufacturing exports involve goods sold by a manufacturer which is not the actual producer. These firms hold a sizeable productivity premium and many superstar firms are not super-producers. 

Çağatay Bircan, Ralph De Haas, 15 May 2015

Innovation enhances economic growth but the mechanisms that underpin the spread of products remain largely unclear. Based on new micro-data from Russia, this column argues that access to credit helps firms to adopt products and production processes that are new to them. However, there is little evidence that bank credit stimulates in-house R&D. Thus, banks can facilitate the diffusion of technologies within developing countries but their role in pushing the technological frontier is limited.

Andrew W. Lo, Richard T. Thakor, 24 March 2015

R&D-intensive firms such as biopharmaceutical companies operate in a competitive and risky environment. This column presents new evidence on how competition affects the investment decision of R&D-intensive firms. An increase in competition will make the firm increase the R&D investment, and as a response the firm will carry more cash and reduce its debt. Also, more competition will increase the idiosyncratic risk of R&D-intensive firms.

Other Recent Articles: